{"indexed": {"date-parts": [[2025, 8, 19]], "date-time": "2025-08-19T09:54:51Z", "timestamp": 1755597291363, "version": "3.41.2"}, "reference-count": 5, "publisher": "Wiley", "issue": "13", "license": [{"start": {"date-parts": [[2023, 6, 5]], "date-time": "2023-06-05T00:00:00Z", "timestamp": 1685923200000}, "content-version": "vor", "delay-in-days": 0, "URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor"}], "content-domain": {"domain": ["chemistry-europe.onlinelibrary.wiley.com"], "crossmark-restriction": true}, "short-container-title": ["ChemMedChem"], "published-print": {"date-parts": [[2023, 7, 3]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>The status of industrial Medicinal Chemistry was discussed with European Medicinal Chemistry Leaders from large to mid‐sized pharma and CRO companies as well as biotechs. The chemical modality space has expanded recently from small molecules to address new challenging targets. Besides the classical SAR/SPR optimization of drug molecules also their ‘greenness’ has increasing importance. The entire pharma discovery ecosystem has developed significantly. Beyond pharma and academia new key players such as Biotech and integrated CROs as well as Digital companies have appeared and are now to a large extend fueled by VC money. Digitalization is happening everywhere but surprisingly did not change speed and success rates of projects so far. Future Medicinal Chemists will still have to be excellent synthetic chemists but in addition they must be knowledgeable in new computational areas such as data sciences. Their ability to collaborate and to work in teams is key.</jats:p>", "DOI": "10.1002/cmdc.202300127", "type": "journal-article", "created": {"date-parts": [[2023, 6, 7]], "date-time": "2023-06-07T23:59:36Z", "timestamp": 1686182376000}, "update-policy": "https://doi.org/10.1002/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["European Medicinal Chemistry Leaders in Industry (EMCL) – On the Status and Future of Medicinal Chemistry Research in Europe**"], "prefix": "10.1002", "volume": "18", "author": [{"given": "Amjad", "family": "Ali", "sequence": "first", "affiliation": [{"name": "External Discovery Chemistry Merck and Co. Inc.  2000 Galloping Hill Road Kenilworth NJ 07033 USA"}]}, {"given": "Marcus", "family": "Bauser", "sequence": "additional", "affiliation": [{"name": "Research &amp; Early Development Global R&amp;D Leo Pharma  Industriparken 55 2750 Ballerup Denmark"}]}, {"ORCID": "https://orcid.org/0000-0002-7159-1157", "authenticated-orcid": false, "given": "Sophie", "family": "Bertrand", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry Medicine Design, R&amp;D GSK Medicines Research Centre  Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK"}]}, {"given": "Wesley", "family": "Blackaby", "sequence": "additional", "affiliation": [{"name": "Chemistry and Analytical Sciences, Drug Design and Small Molecule Unit Servier Research Institute  125 Chemin de Ronde 78290 Croissy sur Seine France"}]}, {"ORCID": "https://orcid.org/0000-0001-8838-8190", "authenticated-orcid": false, "given": "Christoph", "family": "Boss", "sequence": "additional", "affiliation": [{"name": "Drug Discovery Chemistry Idorsia Pharmaceuticals Ltd.  Hegenheimermattweg 91 4123 Allschwil/BK Switzerland"}]}, {"given": "Martin", "family": "Bossart", "sequence": "additional", "affiliation": [{"name": "Synthetic Medicinal Modalities Sanofi  Industriepark Höchst G838 65926 Frankfurt Germany"}]}, {"ORCID": "https://orcid.org/0000-0001-7869-6835", "authenticated-orcid": false, "given": "Adrian", "family": "Hall", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry UCB Pharma  Chemin Du Foriest 1 1420 Braine-l'Alleud Belgium"}]}, {"given": "Hayley", "family": "Binch", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry Roche Pharma Research &amp; Early Development Roche Innovation Center Basel F. Hoffmann-La Roche Ltd.  Grenzacherstrasse 124 4070 Basel Switzerland"}]}, {"ORCID": "https://orcid.org/0000-0003-4487-2399", "authenticated-orcid": false, "given": "Werngard", "family": "Czechtizky", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry Respiratory and Immunology AstraZeneca  Pepparedsleden 1 43183 Göteborg Sweden"}]}, {"ORCID": "https://orcid.org/0000-0001-8020-4828", "authenticated-orcid": false, "given": "Harrie", "family": "Gijsen", "sequence": "additional", "affiliation": [{"name": "Discovery Chemistry Therapeutics Discovery Janssen Research &amp; Development, A division of Janssen Pharmaceutica NV  Turnhoutseweg 30 2340 Beerse Belgium"}]}, {"given": "Helmut", "family": "Haning", "sequence": "additional", "affiliation": [{"name": "Research &amp; Development, Drug Discovery Sciences, Medicinal Chemistry Bayer AG, Pharmaceuticals, &lt; postCode/&gt;42096  Wuppertal Germany"}]}, {"ORCID": "https://orcid.org/0000-0001-8750-679X", "authenticated-orcid": false, "given": "Ingo V.", "family": "Hartung", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry &amp; Drug Design Merck Healthcare KGaA  Frankfurter Str. 250 64293 Darmstadt Germany"}]}, {"given": "Paul", "family": "Kilburn", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry and Translational DMPK  Lundbeck, Ottiliavej 9 2500 Valby Denmark"}]}, {"ORCID": "https://orcid.org/0009-0006-7863-6844", "authenticated-orcid": false, "given": "Gilbert", "family": "Lassalle", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry Evotec (France), SAS  Campus Curie, 195 Route d'Espagne 31036 Toulouse Cedex France"}]}, {"ORCID": "https://orcid.org/0000-0003-2466-5800", "authenticated-orcid": false, "given": "Ulrich", "family": "Lücking", "sequence": "additional", "affiliation": [{"name": "Chemistry FoRx Therapeutics  Lichtstrasse 35 4056 Basel Switzerland"}]}, {"given": "Jürgen", "family": "Mack", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry Boehringer Ingelheim  Birkendorfer Str. 65 88400 Biberach Germany"}]}, {"given": "Martin", "family": "Missbach", "sequence": "additional", "affiliation": [{"name": "Global Discovery Chemistry Novartis Institutes for BioMedical Research (NIBR)  4002 Basel Switzerland"}]}, {"ORCID": "https://orcid.org/0000-0002-9623-1406", "authenticated-orcid": false, "given": "Leena", "family": "Otsomaa", "sequence": "additional", "affiliation": [{"name": "Medicine Design, R&amp;D Orion Corporation, Orion Pharma  Orionintie 1 02200 Espoo Finland"}]}, {"ORCID": "https://orcid.org/0009-0004-6587-0362", "authenticated-orcid": false, "given": "Antoni", "family": "Torrens", "sequence": "additional", "affiliation": [{"name": "Chemical Collaborations &amp; Strategic Alliances ABAC Therapeutics S.L.  Joan XXIII, 10 08950 Esplugues de Llobregat. Barcelona Spain"}]}, {"given": "Michael", "family": "Wagner", "sequence": "additional", "affiliation": [{"name": "Chemistry and Drug Discovery Dewpoint Therapeutics GmbH  Industriepark Hoechst, G830 65926 Frankfurt Germany"}]}, {"ORCID": "https://orcid.org/0000-0002-8056-0985", "authenticated-orcid": false, "given": "Magnus", "family": "Walter", "sequence": "additional", "affiliation": [{"name": "Chemical Sciences and Process Development Monte Rosa Therapeutics AG  Klybeckstrasse 191, WKL-136.3 4057 Basel Switzerland"}]}, {"ORCID": "https://orcid.org/0000-0003-1308-2730", "authenticated-orcid": false, "given": "Harald", "family": "Weinstabl", "sequence": "additional", "affiliation": [{"name": "Medicinal Chemistry Boehringer Ingelheim  Dr. Boehringer Gasse 5–11 1121 Vienna Austria"}]}, {"ORCID": "https://orcid.org/0000-0002-5874-3443", "authenticated-orcid": false, "given": "Luc", "family": "van Hijfte", "sequence": "additional", "affiliation": [{"name": "Drug Discovery, Symeres  Kerkenbos 1013 6546 BB Nijmegen The Netherlands"}]}, {"given": "Franz", "family": "von Nussbaum", "sequence": "additional", "affiliation": [{"name": "Life Science Chemistry Nuvisan ICB GmbH  Müllerstr. 178 13353 Berlin Germany"}]}], "member": "311", "published-online": {"date-parts": [[2023, 6, 5]]}, "reference": [{"key": "e_1_2_13_1_1", "doi-asserted-by": "publisher", "DOI": "10.1021/acs.jmedchem.0c00176"}, {"key": "e_1_2_13_2_1", "unstructured": "https://transforming-pharma.eu/."}, {"key": "e_1_2_13_3_1", "unstructured": "http://www.imi.europa.eu/projects-results/project-factsheets/melloddy."}, {"key": "e_1_2_13_4_1", "unstructured": "http://www.efmc.info/computational-chemistry."}, {"key": "e_1_2_13_5_1", "unstructured": "https://www.mentimeter.com."}], "container-title": ["ChemMedChem"], "original-title": [], "language": "en", "deposited": {"date-parts": [[2023, 8, 17]], "date-time": "2023-08-17T02:36:18Z", "timestamp": 1692239778000}, "score": 1, "resource": {"primary": {"URL": "https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202300127"}}, "subtitle": [], "short-title": [], "issued": {"date-parts": [[2023, 6, 5]]}, "references-count": 5, "journal-issue": {"issue": "13", "published-print": {"date-parts": [[2023, 7, 3]]}}, "alternative-id": ["10.1002/cmdc.202300127"], "URL": "https://doi.org/10.1002/cmdc.202300127", "archive": ["Portico"], "relation": {}, "ISSN": ["1860-7179", "1860-7187"], "issn-type": [{"type": "print", "value": "1860-7179"}, {"type": "electronic", "value": "1860-7187"}], "subject": [], "published": {"date-parts": [[2023, 6, 5]]}, "assertion": [{"value": "2023-03-02", "order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2023-06-05", "order": 2, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}], "article-number": "e202300127"}